Advertisement

Topics

Northfield Laboratories Company Profile

08:02 EDT 22nd October 2017 | BioPortfolio

Northfield Laboratories Inc. is a leader in developing an oxygen-carrying red blood cell substitute for the treatment of life-threatening blood loss, when an oxygen-carrying fluid is required and red blood cells are not available. Northfield’s product, PolyHeme®, is a human hemoglobin-based temporary oxygen-carrying red blood cell substitute. PolyHeme® simultaneously restores lost blood volume and hemoglobin levels and is designed for rapid, massive infusion. PolyHeme® requires no cross-matching. It is compatible with all blood types and therefore immediately available for infusion. It has an extended shelf life in excess of 12 months. PolyHeme® has been rapidly infused in trauma patients during urgent life-threatening blood loss in sufficiently large quantities to be considered well-tolerated in this patient population. Patient enrollment is now complete in a landmark Phase III, randomized, controlled open-label, multicenter, parallel group study to evaluate the safety and efficacy of PolyHeme® when used to treat severely injured patients in hemorrhagic shock before they reach a hospital. Under the protocol, treatment began at the scene of the injury or in the ambulance, and continued during transport and a 12 hour post-injury period in the hospital. The use of PolyHeme® in this setting has the potential to address a critical, unmet medical need. The study is based on two potential life-saving benefits. The first is starting infusion of an oxygen-carrying fluid at the scene of injury and continuing during transport to the hospital. Because blood is not routinely carried in ambulances, PolyHeme® represents a potential improvement over the current standard of care. The second opportunity is the potential to improve the outcome associated with the use of donated blood in the early hospital period in critically injured patients. Although blood is the current standard of care, there is a growing body of scientific evidence pointing to the adverse immunomodulatory effects of early blood transfusion in trauma patients, specifically the incidence of multiple organ failure and the resultant associated mortality. There are also published data indicating that these same effects may not occur with PolyHeme®. Thus while blood is available in the hospital, PolyHeme® is being evaluated as a potential better alternative for the early care of the injured patient.

Location

1560 Sherman Avenue
Evanston
IL
60201-4800
United States of America

Contact

Phone: 847 864 3500
Email: investor_relations@northfieldlabs.com


News Articles [262 Associated News Articles listed on BioPortfolio]

Automatic Heart Analyzing CADence System Cleared by FDA

AUM Cardiovascular, a company out of Northfield, Minnesota, won FDA clearance for its CADence system, which is a novel combination of a stethoscope and ECG... Read More →

Contrasting IDEXX Laboratories

IDEXX Laboratories and Heska Corporation are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, di...

Enterome to move its research laboratories

Enterome, a pioneer of innovative therapies for microbiome-related diseases announced that the Company is moving its research laboratories to Genopole, a leading biocluster dedicated to biotechnology ...

Impax Laboratories (IPXL) vs. Lannett Co (LCI) Financial Survey

Impax Laboratories and Lannett Co are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, risk...

$0.14 EPS Expected for Impax Laboratories, Inc. (IPXL) This Quarter

Analysts expect Impax Laboratories, Inc. to report earnings per share of $0.14 for the current fiscal quarter, according to Zacks . Four analysts have provided estimates for Impax Laboratories' ea...

Encouraging Heart-Healthy Living: Medline Raises Critical Funds to Support Research and Education

Employees and their families walk to support the 2017 American Heart Association Heart Walk in Northfield Heart disease is the leading cause of death in the United States, ...

#jobs #lifescience Vector Laboratories: Marketing Manager

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Vector Laboratories: Marketing Manager . Competitive Salary and Benefits: Vec...

Abbott Laboratories Q3 Earnings Rise 32%

NORTH CHICAGO (dpa-AFX) - Abbott Laboratories (ABT) released a profit for its third quarter that climbed from last year.The company said its bottom line advanced to $1.16 billion, or $0.66 per sha...

PubMed Articles [171 Associated PubMed Articles listed on BioPortfolio]

Project management: importance for diagnostic laboratories.

The constraints applied on diagnostic laboratories to improve both quality and productivity together with personal shortages incite laboratory managers to constantly optimize the laboratory workflows,...

Survey of laboratory practices for diagnosis of fungal infection in seven Asian countries: An Asia Fungal Working Group (AFWG) initiative.

An online survey of mycology laboratories in seven Asian countries was conducted to assess the status, competence, and services available. Country representatives from the Asia Fungal Working Group (A...

Cancer incidence in female laboratory employees: extended follow-up of a Swedish cohort study.

Work in chemical laboratories is associated with exposure to chemicals, of which some are known or suspected carcinogens. A cohort study of laboratory workers in Stockholm followed until 1992 showed a...

Consistency of BRCA1 and BRCA2 Variant Classifications Among Clinical Diagnostic Laboratories.

Genetic tests of the cancer predisposition genes BRCA1 and BRCA2 inform significant clinical decisions for both physicians and patients. Most uncovered variants are benign, and determining which few a...

CLSI-Based Validation of Manufacturer-Derived Reference Intervals on the Cobas 8000 Platform.

Reference intervals provided by diagnostic test manufacturers should be transferred to clinical laboratories after validation. Although protocols exist, laboratories rarely perform and report on resul...

Clinical Trials [237 Associated Clinical Trials listed on BioPortfolio]

A Comparative Clinical Trial to Evaluate the Safety and Clinical Equivalence of Clotrimazole Troche/Lozenges USP, 10mg (Unique Pharmaceutical Laboratories, India) With Clotrimazole Troche 10mg (Roxane Laboratories Inc., USA) in Subjects With Oropharyngeal

The objectives of this study are to compare the efficacy and safety of Clotrimazole troche/ lozenges USP, 10 mg (Unique Pharmaceutical Laboratories, India) vs. Clotrimazole Troche/ Lozenge...

Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fed Condition

The objective of this study is to determine the relative bioavailability of one 15 mg Meloxicam tablet (Dr. Reddy. Laboratories Ltd.,Generics) versus one 15 mg Mobic (meloxicam) Tablet (Bo...

Bioequivalence Study of Dr.Reddy's Laboratories Limited Finasteride Tablets 1 mg Under Fed Condition

The objective of this study was to compare the single-dose relative bioavailability of Dr. Reddy's Laboratories, Ltd. and Merck & Co. (Propecia®) 1 mg finasteride tablets under fed condi...

Bioequivalence Study of Meloxicam Tablets 15 mg of Dr.Reddy's Laboratories Limited Under Fasting Condition

The objective of this study is to determine the relative bioavailability of one 15 mg Meloxicam tablet (Dr. Reddy. Laboratories Ltd.,Generics) versus one 15 mg Mobic (meloxicam) Tablet (Bo...

Bioequivalence Study of Dr. Reddy's Laboratories Limited, Finasteride Tablets 1 mg Under Fasting Condition

The objective of this study was to compare the single-dose relative bioavailability of Dr. Reddy's Laboratories, Ltd. and Merck & Co. (Propecia®) 1 mg finasteride tablets under fasting c...

Companies [937 Associated Companies listed on BioPortfolio]

Northfield Hospital & Clinics

Northfield Laboratories

Northfield Laboratories Inc. is a leader in developing an oxygen-carrying red blood cell substitute for the treatment of life-threatening blood loss, when an oxygen-carrying fluid is required and red ...

KENT LABORATORIES

Since 1974 KENT LABORATORIES has been a specialist in the production of polyclonal antibodies, radial immunodiffusion kits and conjugated immunoglobulin fractions for manufacturers, universities and l...

Rainbow Scientific, Inc.

Rainbow Scientific, Inc. markets, sells, and distributes state-of-the-art medical diagnostic test kits to both research and clinical laboratories. From our Windsor, Connecticut location, we are commit...

Stepan Company

Stepan Company is a global manufacturer of specialty and intermediate chemicals used in consumer products and industrial application. Stepan is a leading merchant producer of surfactants, which are th...

More Information about "Northfield Laboratories" on BioPortfolio

We have published hundreds of Northfield Laboratories news stories on BioPortfolio along with dozens of Northfield Laboratories Clinical Trials and PubMed Articles about Northfield Laboratories for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Northfield Laboratories Companies in our database. You can also find out about relevant Northfield Laboratories Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...


Corporate Database Quicklinks



Searches Linking to this Company Record